Vertex's kidney disease drug meets main goal in late-stage trial

Core Insights - Vertex Pharmaceuticals announced that its experimental kidney disease drug successfully met the primary endpoint in a late-stage clinical trial [1] Company Summary - Vertex Pharmaceuticals is advancing its pipeline with a focus on treatments for kidney disease, indicating a significant step forward in its research and development efforts [1]